HomeFBLG • NASDAQ
add
Fibrobiologics Inc
Previous close
$11.68
Day range
$9.61 - $11.20
Year range
$6.53 - $55.00
Market cap
330.79M USD
Avg Volume
71.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.48M | 90.18% |
Net income | -9.72M | -537.60% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.45M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.16M | 304.37% |
Total assets | 11.82M | 145.05% |
Total liabilities | 10.57M | 19.82% |
Total equity | 1.25M | — |
Shares outstanding | 32.49M | — |
Price to book | 292.00 | — |
Return on assets | -49.36% | — |
Return on capital | -79.39% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -9.72M | -537.60% |
Cash from operations | -1.60M | -36.49% |
Cash from investing | -2.00K | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -1.60M | -264.07% |
Free cash flow | 6.97M | — |
About
Founded
2021
Headquarters
Website
Employees
10